摘要
目的探讨原发性肝癌晚期患者采用益气活血扶正解毒法辅助治疗的临床效果。方法选取2014年12月至2017年12月本溪中医院肿瘤内科收治的原发性肝癌晚期患者72例作为研究对象,随机分为对照组与试验组,各36例。对照组给予常规治疗,试验组在对照组基础上采用益气活血扶正解毒法治疗。比较两组临床疗效、肿瘤标志物水平、血清学指标、不良反应发生情况与疼痛程度。结果试验组治疗有效率、不良反应发生率与对照组比较,差异无统计学意义(P>0.05);两组治疗后肿瘤标志物水平、血清学指标、视觉模拟评分法(VAS)评分均优于治疗前,且试验组均优于对照组,差异有统计学意义(P<0.05)。结论采用益气活血扶正解毒法辅助治疗原发性肝癌晚期患者临床效果确切,可抑制肿瘤细胞增殖,减轻疼痛,且安全性较高。
Objective To explore the clinical effects of the adjuvant therapy of invigorating qi, activating blood circulation, strengthening and detoxifying method for the patients with late primary liver cancer. Methods From December 2014 to December 2017, 72 patients with late primary liver cancer admitted to Oncology Department of Benxi Hospital of Traditional Chinese medicine were randomly divided into control group and experimental group, with 36 cases each. The control group was given routine treatment, and the experimental group was treated with the method of invigorating qi, activating blood circulation, strengthening and detoxifying method on the basis of the control group. The clinical efficacy, tumor marker level, serological index, adverse reactions and pain degree were compared between the 2 groups. Results There was no significant difference between the experimental group and the control group(P>0.05). After treatment, the tumor marker level, serological index and VAS score of the 2 groups were better than those before treatment, and the experimental group was better than the control group(P<0.05). Conclusion The clinical effects of adjuvant therapy of invigorating qi, activating blood circulation, strengthening and detoxifying method in the treatment of patients with late primary liver cancer is accurate, and it can inhibit the proliferation of tumor cells, relieve pain, and has high safety.
作者
赵华明
刘师
高洋
ZHAO Hua-Ming;LIU Shi;GAO Yang(Department of Oncology,Benxi Hospital of Traditional Chinese Medicine,Benxi 117000;Department of Breast,Benxi Hospital of Traditional Chinese Medicine,Benxi 117000,China;Wutian(China)International Trade Co.,Ltd.Shenyang 110000,China)
出处
《中国药物经济学》
2019年第11期82-85,共4页
China Journal of Pharmaceutical Economics
关键词
肿瘤标志物
原发性肝癌
晚期
益气活血扶正解毒法
Tumor markers
Primary hepatocellular carcinoma
Late
Invigorating qi,activating blood circulation,strengthening and detoxifying method